FDA approves first OTC combo of Tylenol and Naproxen for ‘non-opioid’ pain relief

The FDA recently approved a new over-the-counter medication that combines Tylenol and Naproxen into a single tablet. This development offers a new choice for individuals managing persistent pain, as the combined formula provides up to 12 hours of relief for adults and children aged 12 and older.

Kenvue, the manufacturer, stated that the product is designed to simplify pain management routines. Clinical studies indicated that the combined approach performs better than taking the individual medications separately, achieving pain relief within 30 minutes.

This approval gives patients a non-opioid alternative for ongoing discomfort. By reducing the number of individual pills required throughout the day, the company aims to support better patient adherence to treatment plans. The medication is expected to arrive as a standard option for those looking to manage pain symptoms efficiently without needing a prescription.